ArticleCancers2025

Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial.

Sara Fernández-Castillejo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.